Veracyte Inc (VCYT)
Healthcare
Diagnostics & Research
44.90 $
-3.2%
vs. previous close
Closing price · As of: 3. Aug 2026
Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 46 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14 | 16 | -9.0 | 30 | 30 | 25 | 5.4 | 34 | 45 | 53 | 35 | 46 | 178 | |
| 7.3 | 6.3 | 5.6 | 5.7 | 5.9 | 6.3 | 5.4 | 5.5 | 5.3 | 5.3 | 5.4 | 4.8 | 21 | |
| 7.3 | 7.5 | 8.0 | 9.9 | 8.7 | 9.6 | 11 | 11 | 11 | 11 | 13 | 14 | 49 | |
| -1.6 | 1.4 | -23 | 5.8 | -0.1 | -4.2 | -15 | 1.2 | 6.4 | 5.5 | -12 | 1.7 | 1.9 | |
| 2.8 | 2.5 | 2.1 | 2.8 | 2.2 | 4.1 | 1.8 | 1.3 | 2.8 | 4.3 | 3.0 | 2.9 | 13 | |
| -2.8 | -2.5 | 2.9 | -2.8 | -2.2 | -54 | -52 | -0.2 | 48 | -5.4 | -128 | -14 | -99 | |
| -2.4 | -1.1 | -3.8 | -1.3 | -2.2 | -3.3 | -9.5 | -2.4 | – | – | – | – | – | |
| 0.1 | 0.6 | -0.9 | 0.0 | 10 | -4.5 | -6.5 | -0.6 | 3.0 | -0.1 | -6.6 | 4.1 | 0.3 | |
| 11 | 14 | -7.1 | 27 | 38 | -35 | -53 | 33 | 96 | 47 | -99 | 36 | 80 | |
| 11 | 13 | -11 | 27 | 28 | 20 | 3.5 | 32 | 42 | 48 | 32 | 43 | 165 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.